Rapid establishment of a national surveillance of COVID-19 hospitalizations in Belgium

Author:

Van Goethem NinaORCID,Vilain Aline,Wyndham-Thomas Chloé,Deblonde Jessika,Bossuyt Nathalie,Lernout Tinne,Rebolledo Gonzalez Javiera,Quoilin Sophie,Melis Vincent,Van Beckhoven Dominique

Abstract

Abstract Background In response to the COVID-19 epidemic, caused by a novel coronavirus, it was of great importance to rapidly collect as much accurate information as possible in order to characterize the public health threat and support the health authorities in its management. Hospital-based surveillance is paramount to monitor the severity of a disease in the population. Methods Two separate surveillance systems, a Surge Capacity survey and a Clinical survey, were set up to collect complementary data on COVID-19 from Belgium’s hospitals. The Surge Capacity survey collects aggregated data to monitor the hospital capacity through occupancy rates of beds and medical devices, and to follow a set of key epidemiological indicators over time. Participation is mandatory and the daily data collection includes prevalence and incidence figures on the number of COVID-19 patients in the hospital. The Clinical survey is strongly recommended by health authorities, focusses on specific patient characteristics and relies on individual patient data provided by the hospitals at admission and discharge. Conclusions This national double-level hospital surveillance was implemented very rapidly after the first COVID-19 patients were hospitalized and revealed to be crucial to monitor hospital capacity over time and to better understand the disease in terms of risk groups and outcomes. The two approaches are complementary and serve different needs.

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Reference17 articles.

1. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19%2D%2D-11-march-2020.

2. World Health Organization. Coronavirus disease (COVID-2019) situation reports. [Internet]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.

3. Spiteri G, Fielding J, Diercke M, Campese C, Enouf V, Gaymard A, et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Eurosurveillance [Internet]. 2020 [cited 2020 Jul 9];25. Available from: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.9.2000178.

4. Federal Public Service (FPS) Health, Food Chain Safety and Environment. “One repatriated Belgian has tested positive for the novel coronavirus” [Internet]. 2020. Available from: https://www.info-coronavirus.be/en/news/one-repatriated-belgian-has-tested-positive-for-the-novel-coronavirus/.

5. Sciensano. COVID-19 epidemiological update [Internet]. Available from: https://covid-19.sciensano.be/fr/covid-19-situation-epidemiologique.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3